Burning Rock Biotech Ltd (BNR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 30M 60M 90M FY21: 79.7M FY22: 81.7M FY23: 75.7M FY24: 70.7M FY25: 77.2M FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 20M 40M 60M FY21: 57.1M FY22: 55.1M FY23: 51.2M FY24: 49.6M FY25: 57.6M FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-150M -100M -50M 0 50M 100M 150M FY21: -125.1M FY22: -142.1M FY23: -94.3M FY24: -49M FY25: -7.8M FY21 FY22 FY23 FY24 FY25

Net Income Annual

-150M -100M -50M 0 50M 100M 150M FY21: -125M FY22: -140.8M FY23: -92.1M FY24: -47.5M FY25: -7.9M FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 10M 20M 30M FY21: 22.6M FY22: 26.6M FY23: 24.5M FY24: 21M FY25: 19.5M FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-90M -60M -30M 0 30M 60M 90M FY21: -75M FY22: -66.2M FY23: -36M FY24: -12.6M FY25: -4.1M FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-120M -80M -40M 0 40M 80M 120M FY21: -107.1M FY22: -75.2M FY23: -37.2M FY24: -13.4M FY25: -4.8M FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.